Corporate weekly highlights—24 May 2018

Corporate weekly highlights—24 May 2018

This week’s edition of Corporate highlights includes news analysis of the Supreme Court’s judgment in Rock Advertising Ltd v MWB Business Exchange Ltd on no oral variation clauses and the BEIS committee’s verdict on Carillion. We have also published several new Q&As including one on the impact of the GDPR on M&A transactions.

Contract law for Corporate lawyers

Contract law in the Supreme Court—a sensible break with the common law? (Rock Advertising Ltd v MWB Business Exchange Centres Ltd)

The Supreme Court has unanimously held that licence fee payments under a licence agreement containing a ‘no oral modification’ (NOM) clause could not be varied by oral agreement between representatives of the licensor and the licensee, in Rock Advertising v MWB Business. Lawyers at Bird and Bird, Clifford Chance, Charles Russell Speechlys, Herbert Smith Freehills, Howard Kennedy, Stewarts and Wedlake Bell discuss the impact of this decision which will have 'wide ramifications for all types of contracts' and give ‘real meaning and support to NOM clauses within contracts’.

In a separate analysis piece, Michael Paget, at Cornerstone Barristers, examines the decision and concludes that it will make contractual relations more certain. Any party who has the benefit of a contract with a NOM clause no longer needs to worry about the risk of an oral variation unless they have allowed the other party to rely on that apparent variation. It should reduce the risk that companies are inadvertently bound into a variation without senior management’s agreement.

For further information, see Contract law in the Supreme Court—a sensible break with the common law? (Rock Advertising Ltd v MWB Business Exchange Centres Ltd) and LNB News 16/05/2018 112.

Corporate Crime for corporate lawyers

Corporate Manslaughter and Corporate Homicide Act 2007: ten-year review: part one

In the first of a three-part series on the ten-year anniversary of the Corporate Manslaughter and Corporate Homicide Act 2007 (CMCHA 2007), Kevin Bridges, partner and head of health

Subscription Form

Related Articles:
Latest Articles:

Register for free to access this article and thousands of others like it.
Already a subscriber? Login
RELX (UK) Limited, trading as LexisNexis, and our LexisNexis Legal & Professional group companies will contact you to confirm your email address. You can manage your communication preferences via our Preference Centre. You can learn more about how we handle your personal data and your rights by reviewing our  Privacy Policy.

Access this article and thousands of others like it free by subscribing to our blog.

Read full article

Already a subscriber? Login

About the author: